|
⚲
|
| Keyboard |
| Loewy Caroline M
✚
|
|
|---|---|
| CIK # | 0001367451 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001367451] | |
| 4 | [0001367451] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| eFFECTOR Therapeutics Inc | |
| Loewy Caroline M | |
| CymaBay Therapeutics Inc | |
| CERO Therapeutics Holdings Inc | |
| PhaseBio Pharmaceuticals Inc | |
| Lorus Therapeutics Inc | |
| Zogenix Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
eFFECTOR Therapeutics Inc EFTR
Stock Option (Right to Buy) · derivative
|
2024-06-13 | Grant | 800 | $0.00 | |
|
CymaBay Therapeutics Inc CBAY
Employee Stock Option (right to buy) · derivative
|
2024-03-22 | Disposed to issuer | 16,000 | ||
|
CymaBay Therapeutics Inc CBAY
Employee Stock Option (right to buy) · derivative
|
2024-03-22 | Disposed to issuer | 27,705 | ||
|
CymaBay Therapeutics Inc CBAY
Employee Stock Option (right to buy) · derivative
|
2024-03-22 | Disposed to issuer | 14,010 | ||
|
CymaBay Therapeutics Inc CBAY
Employee Stock Option (right to buy) · derivative
|
2024-03-22 | Disposed to issuer | 67,000 | ||
|
CymaBay Therapeutics Inc CBAY
Employee Stock Option (right to buy) · derivative
|
2024-03-22 | Disposed to issuer | 25,000 | ||
|
CymaBay Therapeutics Inc CBAY
Employee Stock Option (right to buy) · derivative
|
2024-03-22 | Disposed to issuer | 30,000 | ||
|
CymaBay Therapeutics Inc CBAY
Employee Stock Option (right to buy) · derivative
|
2024-03-22 | Disposed to issuer | 15,000 | ||
|
CymaBay Therapeutics Inc CBAY
Employee Stock Option (right to buy) · derivative
|
2024-03-22 | Disposed to issuer | 7,500 | ||
|
CymaBay Therapeutics Inc CBAY
Employee Stock Option (right to buy) · derivative
|
2024-03-22 | Disposed to issuer | 32,000 | ||
|
CymaBay Therapeutics Inc CBAY
Employee Stock Option (right to buy) · derivative
|
2024-03-22 | Disposed to issuer | 49,245 | ||
|
eFFECTOR Therapeutics Inc EFTR
Stock Option (Right to Buy) · derivative
|
2024-02-19 | Grant | 2,000 | $0.00 | |
|
CERO Therapeutics Holdings Inc CERO
Class A Common Stock
|
2024-02-14 | Other | 5,828 | ||
|
CymaBay Therapeutics Inc CBAY
Stock Option (right to buy) · derivative
|
2024-01-24 | Grant | 14,010 | $0.00 | |
|
eFFECTOR Therapeutics Inc EFTR
Stock Option (Right to Buy) · derivative
|
2023-09-09 | Grant | 40,000 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Restricted Stock Units · derivative
|
2023-05-19 | Option exercise | 3,750 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2023-05-19 | Option exercise | 3,750 | ||
|
CymaBay Therapeutics Inc CBAY
Stock Option (right to buy) · derivative
|
2023-01-25 | Grant | 25,000 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Non-employee Director Stock Option (right to buy) · derivative
|
2022-05-19 | Grant | 17,500 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Restricted Stock Units · derivative
|
2022-05-19 | Grant | 3,750 | $0.00 | |
| showing 20 of 43 most recent transactions | |||||